Pancreatic cancer is a terminal disease with high mortality and very poor prognosis. A sensitive and quantitative analysis of KRAS mutations in pancreatic cancer provides a tool not only to understand the biological mechanisms of pancreatic cancer but also for diagnosis and treatment monitoring. Digital polymerase chain reaction (PCR) is a promising tool for KRAS mutation analysis, but current methods generally require a complex microfluidic handling system, which can be challenging to implement in routine research and point-of-care clinical diagnostics. Here, we present a droplet-array SlipChip (da-SlipChip) for the multiplex quantification of KRAS G12D, V, R, and C mutant genes with the wild-type (WT) gene background by dual color (FAM/RO...
<div><p>In cancer research, the accuracy of the technology used for biomarkers detection is remarkab...
Kirsten RAS (KRAS) is a small GTPase that plays a key role in Ras/mitogen-activated protein kinase s...
International audienceSomatic mutations within tumoral DNA can be used as highly specific biomarkers...
cogene homolog) alleles may provide information in addition to that provided by standard mutation-de...
Applications of precision oncology strategies rely on accurate tumor genotyping from clinically avai...
© 2015 Pender et al. This is an open access article distributed under the terms of the Creative Comm...
Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung ca...
Detection and quantification of tumor-derived KRAS and NRAS mutations in plasma cell-free DNA (cfDNA...
International audienceWe demonstrate an accurate and sensitive quantification of mutated KRAS oncoge...
KRAS mutation is a major regulator in the tumor progression of pancreatic cancer. Here, we compared ...
BACKGROUND: Molecular techniques are relevant to modern cytopathology, but their implementation is ...
<div><p>Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven...
Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung ca...
International audienceWe describe a droplet microfluidics method to screen for multiple mutations of...
The KRAS oncogene is involved in the pathogenesis of several types of cancer, particularly colorecta...
<div><p>In cancer research, the accuracy of the technology used for biomarkers detection is remarkab...
Kirsten RAS (KRAS) is a small GTPase that plays a key role in Ras/mitogen-activated protein kinase s...
International audienceSomatic mutations within tumoral DNA can be used as highly specific biomarkers...
cogene homolog) alleles may provide information in addition to that provided by standard mutation-de...
Applications of precision oncology strategies rely on accurate tumor genotyping from clinically avai...
© 2015 Pender et al. This is an open access article distributed under the terms of the Creative Comm...
Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung ca...
Detection and quantification of tumor-derived KRAS and NRAS mutations in plasma cell-free DNA (cfDNA...
International audienceWe demonstrate an accurate and sensitive quantification of mutated KRAS oncoge...
KRAS mutation is a major regulator in the tumor progression of pancreatic cancer. Here, we compared ...
BACKGROUND: Molecular techniques are relevant to modern cytopathology, but their implementation is ...
<div><p>Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven...
Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung ca...
International audienceWe describe a droplet microfluidics method to screen for multiple mutations of...
The KRAS oncogene is involved in the pathogenesis of several types of cancer, particularly colorecta...
<div><p>In cancer research, the accuracy of the technology used for biomarkers detection is remarkab...
Kirsten RAS (KRAS) is a small GTPase that plays a key role in Ras/mitogen-activated protein kinase s...
International audienceSomatic mutations within tumoral DNA can be used as highly specific biomarkers...